A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration.


Journal

Small GTPases
ISSN: 2154-1256
Titre abrégé: Small GTPases
Pays: United States
ID NLM: 101530974

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 13 5 2017
medline: 10 4 2020
entrez: 13 5 2017
Statut: ppublish

Résumé

Cell migration is central to many developmental, physiologic and pathological processes, including cancer progression. The Ral GTPases (RalA and RalB) which act down-stream the Ras oncogenes, are key players in the coordination between membrane trafficking and actin polymerization. A major direct effector of Ral, the exocyst complex, works in polarized exocytosis and is at the center of multiple protein-protein interactions that support cell migration by promoting protrusion formation, front-rear polarization, and extra-cellular matrix degradation. In this review we describe the recent advancements in deciphering the molecular mechanisms underlying this role of Ral via exocyst on cell migration. Among others, we will discuss the recently identified cross-talk between Ral and Rac1 pathways: exocyst binds to a negative regulator (the RacGAP SH3BP1) and to the major effector (the Wave Regulatory Complex, WRC) of Rac1, the master regulator of protrusions. Next challenge will be to better characterize the dynamics in space and in time of these molecular interplays, to better understand the pleiotropic functions of Ral in both normal and cancer cells.

Identifiants

pubmed: 28498728
doi: 10.1080/21541248.2017.1310649
pmc: PMC6748358
doi:

Substances chimiques

GTPase-Activating Proteins 0
Neoplasm Proteins 0
RAC1 protein, human 0
Ralb protein, human 0
SH3BP1 protein, human 0
RALA protein, human EC 3.6.1.-
rac1 GTP-Binding Protein EC 3.6.5.2
ral GTP-Binding Proteins EC 3.6.5.2
ras Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

323-330

Références

Biochem Biophys Res Commun. 2015 Nov 27;467(4):785-91
pubmed: 26498519
Dev Cell. 2012 Aug 14;23(2):397-411
pubmed: 22898781
J Cell Sci. 2015 Aug 15;128(16):2957-64
pubmed: 26240175
J Cell Sci. 2008 Sep 1;121(Pt 17):2880-91
pubmed: 18697830
Oncogene. 2005 Jan 13;24(3):329-35
pubmed: 15467745
Sci Rep. 2015 Dec 04;5:17527
pubmed: 26634649
Development. 1996 Feb;122(2):409-18
pubmed: 8625792
Mol Cell Biol. 2006 Jan;26(2):727-34
pubmed: 16382162
J Cell Biol. 2013 Dec 23;203(6):1063-79
pubmed: 24344185
J Biochem. 2015 May;157(5):285-99
pubmed: 25796063
Cancer Cell Int. 2011 Jun 29;11(1):22
pubmed: 21714887
Cancer Res. 2005 Aug 15;65(16):7111-20
pubmed: 16103060
Mol Biol Cell. 2004 Jun;15(6):2549-57
pubmed: 15034142
Trends Cell Biol. 2005 Jun;15(6):327-32
pubmed: 15953551
Mol Cell Biol. 1995 Aug;15(8):4578-84
pubmed: 7623849
Dev Cell. 2012 May 15;22(5):967-78
pubmed: 22595671
Cell. 2011 Nov 23;147(5):992-1009
pubmed: 22118458
Mol Cell. 2011 Jun 10;42(5):650-61
pubmed: 21658605
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
J Biol Chem. 1995 Sep 22;270(38):22473-7
pubmed: 7673236
J Cell Biol. 2008 Jun 16;181(6):985-98
pubmed: 18541705
Curr Biol. 2012 Aug 21;22(16):1510-5
pubmed: 22748316
Dev Cell. 2013 Aug 12;26(3):266-78
pubmed: 23948253
Nat Struct Mol Biol. 2016 Jan;23(1):59-66
pubmed: 26656853
Mol Biol Cell. 2009 Aug;20(16):3763-71
pubmed: 19535457
Mol Cell Biol. 2012 Apr;32(8):1374-86
pubmed: 22331470
Biochim Biophys Acta. 2014 Dec;1843(12):2976-2988
pubmed: 25219551
PLoS One. 2012;7(6):e39602
pubmed: 22761837
Mol Cell Biol. 2001 Sep;21(17):5958-69
pubmed: 11486034
Sci Rep. 2015 Jul 08;5:11759
pubmed: 26152517
J Cell Biol. 2015 Oct 12;211(1):27-37
pubmed: 26459596
Cell. 1995 Feb 24;80(4):533-41
pubmed: 7867061
Nat Cell Biol. 2006 Dec;8(12):1383-8
pubmed: 17086175
J Cell Sci. 2012 May 15;125(Pt 10):2381-92
pubmed: 22344265
Bioessays. 2010 Feb;32(2):119-31
pubmed: 20091750
J Cell Sci. 2014 Feb 1;127(Pt 3):686-99
pubmed: 24284074
Nat Commun. 2014 Sep 11;5:4857
pubmed: 25209408
Biochem Biophys Res Commun. 2014 Nov 28;454(4):560-5
pubmed: 25450693
J Biosci. 2014 Mar;39(1):145-55
pubmed: 24499799
Cell Rep. 2013 Dec 12;5(5):1159-68
pubmed: 24290760
Commun Integr Biol. 2011 Nov 1;4(6):772-4
pubmed: 22446552
Cell. 2017 Jan 26;168(3):400-412.e18
pubmed: 28129539
Nat Commun. 2015 May 13;6:7164
pubmed: 25968605
Nat Cell Biol. 2009 Jan;11(1):71-7
pubmed: 19060892
PLoS Biol. 2009 Nov;7(11):e1000235
pubmed: 19885391
Oncotarget. 2017 Jan 17;8(3):4484-4500
pubmed: 27835861
Curr Biol. 2006 Dec 19;16(24):2385-94
pubmed: 17174914
Small GTPases. 2018 Nov 2;9(6):445-451
pubmed: 27875100
EMBO J. 2011 Aug 26;30(19):3913-27
pubmed: 21873980
Nature. 2009 Sep 3;461(7260):99-103
pubmed: 19693013
J Cell Biol. 2006 Sep 11;174(6):877-88
pubmed: 16966426
J Cell Sci. 2016 Oct 15;129(20):3756-3769
pubmed: 27591259

Auteurs

Giulia Zago (G)

a Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University , Paris , France.
b ART group, Inserm U830 , Paris , France.

Marco Biondini (M)

a Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University , Paris , France.
b ART group, Inserm U830 , Paris , France.

Jacques Camonis (J)

a Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University , Paris , France.
b ART group, Inserm U830 , Paris , France.

Maria Carla Parrini (MC)

a Institut Curie, Centre de Recherche, Paris Sciences et Lettres Research University , Paris , France.
b ART group, Inserm U830 , Paris , France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH